DESTINY 05 trial - in high risk her - 2 positive #breastcancer - 53% reduction in invasive disease free survival with TDXd - @NSABPFoundation @myesmo.bsky.social @oncoalert.bsky.social ! Honored to be part of the study ! @clevelandclinic.bsky.social

It was a beautiful and blessed weekend for the Abraham family—our son Abel married Kathryn!

From improving efficiency to advancing research, AI is transforming oncology. I joined @Shepard Dale on the @CleClinicMD Cancer Advances podcast to discuss what this means for patients and providers. #CleClinicCancer cle.clinic/41OwRO8

David Baltimore, Nobel-Winning Molecular Biologist, Dies at 87 www.nytimes.com/2025/09/07/s...

It is Bike VeloSano weekend in #cleveland Thank you for coming together to raise money for cancer research @clevelandclinic.bsky.social ! Science and research saves lives !!

Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy - The Lancet www.thelancet.com/journals/lan...

ascopubs.org/doi/10.1200/... @ascocancer.bsky.social

We are excited to welcome Dr. Santhosh Rao as the Medical Director of the HemOnc team @ClevelandClinic Akron General! In addition to general oncology - he will be focusing on building a Genito Urinary Medical Oncology Program in @ClevelandClinic Southern Market

Pleaase join me in congratulating Nancy Musoke M.D, third year HemOnc Fellow Cleveland Clinic the reciepient of CLL Society’s 2025 Integrative Medicine Award. "Curcumin, Exercise and Placebo Effects on CLL / SLL Progression and Immune Function

Human Epidermal Growth Factor Receptor 2 Positivity a Moving Target in the Era of Antibody-Drug Conjugates | JCO Oncology Practice ascopubs.org/doi/10.1200/... @oncoalert.bsky.social

Outstanding talk on AI in healthcare by @neilmehtamd.medsky.social @clevelandclinic.bsky.social Artificial intelligence summit!

Wonderful to be part of one of the best cancer programs in the country as per @newsweek.com rankings.newsweek.com/americas-bes... @clevelandclinic.bsky.social

My conversations with Dr. Grobmyer of @clevelandclinic.bsky.social @ascopost.bsky.social ascopost.com/news/june-20...

Congratulations to the outstanding group of fellows graduating from @clevelandclinic.bsky.social Hematology and Medical Oncology Department in 2025! We are so proud of them and wish them all the best !!

First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer @nejm.org @ascocancer.bsky.social @clevelandclinic.bsky.social

First-Line Camizestrant for Emerging ESR1-Mutated Advanced Breast Cancer | New England Journal of Medicine www.nejm.org/doi/full/10....

Wonderful to be part of the editorial board members of @ascopost.bsky.social ! #1 oncology news paper in the world ! Voice of @ascocancer.bsky.social

Thank you @theaacr.bsky.social for your leadership in advocating for cancer research! @ascocancer.bsky.social

www.nejm.org/doi/full/10.... @oncoalert.bsky.social

www.nejm.org/doi/full/10.... @oncoalert.bsky.social

Looking forward to seeing you at @ascocancer.bsky.social 2025 meeting - please visit @clevelandclinic.bsky.social booth

We are looking for exceptional doctors to join our HemOnc team - Ohio/ Florida - if you are attending @ascocancer.bsky.social meeting please reach out jobs.clevelandclinic.org/job/16715724...

Thanks to the Canton community for coming together to raise money for supporting women undergoing cancer treatment @clevelandclinic.bsky.social Mercy Hospital

Glory Days: Celebrating Two Decades of Advances in #Cancer Care on the 20th Anniversary of JCO Oncology Practice. ascopubs.org/doi/full/10.... @ascocancer.bsky.social #CancerCare #FinancialToxicity #CancerResearch @ethicsdoctorp.bsky.social @fumikochino.bsky.social @jameabraham.bsky.social

Excellent review article by @ptarantinomd.bsky.social on redefining Her-2 testing @ethicsdoctorp.bsky.social @acochran12733.bsky.social ascopubs.org/doi/10.1200/... @oncoalert.bsky.social

Nurses are the backbone of compassionate care! We are privileged to have some of the best nurses in the world @clevelandclinic.bsky.social #happynursesweek!

Looking forward to the oncology update in June 18th 2025 @clevelandclinic.bsky.social www.clevelandclinicmeded.com/live/courses...

Health Care, Physics, and Finance: The Complex Equation of Outpatient CAR T-Cell Therapy | JCO Oncology Practice ascopubs.org/doi/10.1200/...

Congratulations and proud of our son “Dr. Abel Abraham” freshly minted MD from @neomededu.bsky.social !

Congratulations to Dr. Frank Papay of @clevelandclinic.bsky.social for the inspiring commencement speech at the @neomededu.bsky.social medical school graduation!

consultqd.clevelandclinic.org/are-your-pat... @clevelandclinic.bsky.social

www.clevelandclinicmeded.com/live/courses... @clevelandclinic.bsky.social

consultqd.clevelandclinic.org/hematology-c... @clevelandclinic.bsky.social

World lost a leader with a clear moral clarity!!

This could be practice changing once we have the overall survival data www.astrazeneca.com/media-centre...

🙏 for sharing @jameabraham.bsky.social - we share our learnings from Sarah Cannon Transplant and Cellular Therapy Network outpatient #CARTcell program (200+ patients treated in 2024)

Excellent review article by @bldcancerdoc.bsky.social Outpatient Administration of Chimeric Antigen Receptor T-Cell Therapy Using Remote Patient Monitoring | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @oncoalert.bsky.social

Congratulations to Dr. Tiffany Onger who is selected as an 40 under, 40 emerging leaders bpacf.org/new-events/ @clevelandclinic.bsky.social

Had a wonderful editorial meeting at @ascocancer.bsky.social headquarters under the leadership of EIC @ethicsdoctorp.bsky.social @acochran12733.bsky.social @fumikochino.bsky.social @ryannipp.bsky.social and others !

Cancer-Related Cognitive Impairment: A Practical Guide for Oncologists | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @ascocancer.bsky.social

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial | JCO Oncology Practice ascopubs.org/doi/10.1200/... @acochran12733.bsky.social @ascocancer.bsky.social

asco.quorum.us/action_cente... @ascocancer.bsky.social

Taletrectinib in ROS1+ Non–Small Cell Lung Cancer: TRUST | Journal of Clinical Oncology ascopubs.org/doi/10.1200/... @n8pennell.bsky.social @ascocancer.bsky.social @oncoalert.bsky.social

my.clevelandclinic.org/podcasts/can... @clevelandclinic.bsky.social